Islam Kazi, Islam Rahib, Nguyen Ivan, Malik Hassan, Pirzadah Humza, Shrestha Barsha, Lentz Isabella B, Shekoohi Sahar, Kaye Alan D
Central State University, 1400 Brush Row Road, Wilberforce, OH, 45384, USA.
LSU Health Sciences Center New Orleans School of Medicine, 1901 Gravier Street, New Orleans, LA, 70112, USA.
Adv Ther. 2025 Jun;42(6):2659-2678. doi: 10.1007/s12325-025-03185-9. Epub 2025 Apr 19.
Diabetes mellitus is a metabolic disorder, characterized by elevated blood sugar levels (hyperglycemia) and insulin dysregulation. This disease is associated with morbidity and mortality, including significant potential vascular complications. High levels of hyperglycemia lead to not only elevated levels of reactive oxygen species but also advanced glycation end products, which are detrimental to the vascular endothelium and reduce protective compounds such as nitric oxide and prostacyclin. This damage contributes to the development of both macrovascular and microvascular complications. The present investigation explores the pathophysiological mechanisms of diabetic vascular complications and evaluates current management strategies, including lifestyle modifications, pharmacological treatments, and emerging therapies. The review underscores the importance of ongoing progress in diabetes management and patient education to lead to optimal patient-health outcomes and quality of life for individuals with diabetes mellitus.
糖尿病是一种代谢紊乱疾病,其特征为血糖水平升高(高血糖症)和胰岛素调节异常。这种疾病与发病率和死亡率相关,包括严重的潜在血管并发症。高水平的高血糖不仅会导致活性氧物质水平升高,还会产生晚期糖基化终末产物,这些物质对血管内皮有害,并会减少一氧化氮和前列环素等保护性化合物。这种损伤会促使大血管和微血管并发症的发生。本研究探讨了糖尿病血管并发症的病理生理机制,并评估了当前的管理策略,包括生活方式改变、药物治疗和新兴疗法。该综述强调了在糖尿病管理和患者教育方面不断取得进展对于实现糖尿病患者最佳健康结局和生活质量的重要性。
Cardiovasc Diabetol. 2009-4-29
Arq Bras Endocrinol Metabol. 2008-3
Acta Pharmacol Sin. 2018-6-4
Nutr Metab Cardiovasc Dis. 2013-6-17
Arq Bras Endocrinol Metabol. 2007-3
Antioxidants (Basel). 2025-8-14
Biomolecules. 2025-8-19
Channels (Austin). 2025-12
Am J Med Open. 2023-1-18
Front Endocrinol (Lausanne). 2024
Front Endocrinol (Lausanne). 2024-4-5
Public Health Nutr. 2024-4-11
Signal Transduct Target Ther. 2024-2-28
Ther Adv Endocrinol Metab. 2024-1-27
Front Clin Diabetes Healthc. 2023-12-8
Diabetes Care. 2024-1-1